Toll Free: 1-888-928-9744

Parenteral Nutrition Market Analysis, By Nutrition Type (Carbohydrates, Parenteral Lipid Emulsion, Single Dose Amino Acid Solution, Trace Elements, Vitamins and Minerals) And Segment Forecasts To 2024

Published: May 29, 2016 | Pages: 91 | Publisher: Grand View Research | Industry: Pharmaceutical | Report Format: Electronic (PDF)

The global parenteral nutrition market is expected to reach USD 7.3 billion by 2024, according to a new report by Grand View Research, Inc. The increasing natality rate, the growing malnutrition coupled with the prevalence of chronic conditions such as cancer and gastro-intestinal tract diseases are expected to boost the market over the forecast period.

The presence of malnourished children in the developing countries leading to the rise in the natality rate and the rising geriatric population suffering from a deficiency of essential nutrients are some of the major factors that are expected to fuel the global parenteral nutrition market.

According to the WHO around 40.0% patients across the world were malnourished in 2010. The study also indicated that about one-third of the patients in Europe were malnourished in 2012, thereby fueling industry growth.

According to the statistics provided by the World Bank Group, India had the highest natality rate followed by China in 2012. Moreover, a consistent increase in the rate of natality was observed in the European countries such as the U.K. and France. Therefore, Asia Pacific and Europe are expected to witness the fastest growth over the forecast.

North America is expected to witness lucrative growth due to the increase in consumer awareness paired with the increasing healthcare costs. As parenteral nutrition products are available in the home health care sector, it further facilitates the market growth due to the increasing trend in home health care. The increasing incidence of heart diseases is another vital driver. According to the WHO around 49.0% of the American population is endangered with the risk of cardiac arrest.

Further key findings from the study suggest:

North America is expected to dominate the overall market with a revenue share of about40.0% in 2024, owing to the increasing incidences of heart diseases coupled with the rise in home health care.

Asia Pacific and Europe are anticipated to be the fastest growing region with a CAGR of over5.5% over the forecast period. The rise in the natality rate, rising geriatric population and the growing awareness regarding the importance of nutritional value and its impact on health are the vital impact rendering drivers for the region.

Key players of the industry include Baxter International, Inc., Hospira, Inc., B. Braun Melsungen AG, Grifols International S.A., Fresenius Kabi AG, Otsuka Pharmaceutical Factory, Inc., Actavis, Inc., Sichuan Kelun Pharmaceutical Co., Ltd. Most of these companies have been in the business for over a decade and are bringing in expertise and technological advancements that are expected to help them sustain over the forecast period.
 Table of Contents

Chapter 1. Methodology and Scope
                   1.1. Research Methodology
                   1.2. Research Scope & Assumptions
                   1.3. List of Data Sources
Chapter 2. Executive Summary
                   2.1. Parenteral Nutrition Market- Industry Snapshot and Key Buying Criteria, 2015
Chapter 3. Parenteral Nutrition Industry Outlook
                   3.1. Parenteral Nutrition Market Segmentation
                   3.2. Parenteral Nutrition Market Size and Growth Prospects
                   3.3. Parenteral Nutrition Market Dynamics
                        3.3.1. Market Driver Analysis
                             3.3.1.1. Growing base of geriatric population 
                             3.3.1.2. Growing prevalence of chronic diseases
                                   3.3.1.2.1. Cancer
                                   3.3.1.2.2. AIDS
                                   3.3.1.2.3. Gastrointestinal Disorders
                             3.3.1.3. Increasing incidences of malnutrition
                        3.3.2. Market Restraint Analysis
                             3.3.2.1. High risk of infection during administration of fluids
                             3.3.2.2. Increasing preference for enteral nutrition
                   3.4. Key Opportunities Prioritized
                   3.5. Industry Analysis - Porter's
                   3.6. Parenteral Nutrition Company Market Share/Competitive Landscape, 2015
                   3.7. Parenteral Nutrition Market PESTEL Analysis, 2015
Chapter 4. Parenteral nutrition Type Of Nutrition Outlook
                   4.1. Market Share, By Type of Nutrition, 2015 & 2024
                   4.2. Carbohydrates
                        4.2.1. Market Estimates and Forecasts, 2013 - 2024 (USD Million)
                   4.3. Parenteral Lipid Emulsion 
                        4.3.1. Market Estimates and Forecasts, 2013 - 2024 (USD Million)
                   4.4. Single Dose Amino Acid Solution
                        4.4.1. Market Estimates and Forecasts, 2013 - 2024 (USD Million)
                   4.5. Trace Elements
                        4.5.1. Market Estimates and Forecasts, 2013 - 2024 (USD Million)
                   4.6. Vitamins and Minerals
                        4.6.1. Market Estimates and Forecasts, 2013 - 2024 
Chapter 5. Parenteral Nutrition Regional Outlook
                   5.1. Market Share By Region, 2015 & 2024
                   5.2. North America
                        5.2.1. Market Estimates and Forecasts, by Type of Nutrition, 2013 - 2024 (USD Million)
                             5.2.1.1. U.S. Market Estimates and Forecasts
                             5.2.1.2. Canada Market Estimates and Forecasts
                   5.3. Europe
                        5.3.1. Market Estimates and Forecasts, by Type of Nutrition, 2013 - 2024 (USD Million)
                             5.3.1.1. Germany Market Estimates and Forecasts
                             5.3.1.2. UK Market Estimates and Forecasts
                   5.4. Asia Pacific
                        5.4.1. Market Estimates and Forecasts, by Type of Nutrition, 2013 - 2024 (USD Million)
                             5.4.1.1. Japan Market Estimates and Forecasts
                             5.4.1.2. China Market Estimates and Forecasts
                   5.5. Latin America
                        5.5.1. Market Estimates and Forecasts, by Type of Nutrition, 2013 - 2024 (USD Million)
                             5.5.1.1. Argentina Estimates and Forecasts
                             5.5.1.2. Brazil Estimates and Forecasts
                   5.6. MEA
                        5.6.1. MEA Market Estimates and Forecasts, by Type of Nutrition, 2013 - 2024 (USD Million)
                             5.6.1.1. South Africa Estimates and Forecasts
                             5.6.1.2. Saudi Arabia Estimates and Forecasts
Chapter 6. Competitive Landscape 
                   6.1. B. Braun Melsungen AG
                        6.1.1. Company Overview
                        6.1.2. Financial Performance
                        6.1.3. Product Benchmarking
                        6.1.4. Strategic Initiatives
                   6.2. Baxter International, Inc.
                        6.2.1. Company Overview
                        6.2.2. Financial Performance
                        6.2.3. Product Benchmarking
                        6.2.4. Strategic Initiatives
                   6.3. Fresenius Kabi AG
                        6.3.1. Company Overview
                        6.3.2. Financial Performance
                        6.3.3. Product Benchmarking
                        6.3.4. Strategic Initiatives
                   6.4. Hospira, Inc.
                        6.4.1. Company Overview
                        6.4.2. Financial Performance
                        6.4.3. Product Benchmarking
                        6.4.4. Strategic Initiatives
                   6.5. Actavis, Inc.
                        6.5.1. Company Overview
                        6.5.2. Financial Performance
                        6.5.3. Product Benchmarking
                        6.5.4. Strategic Initiatives
                   6.6. Grifols International S.A.
                        6.6.1. Company Overview
                        6.6.2. Financial Performance
                        6.6.3. Product Benchmarking
                        6.6.4. Strategic Initiatives
                   6.7. Otsuka Pharmaceutical Factory, Inc.
                        6.7.1. Company Overview
                        6.7.2. Financial Performance
                        6.7.3. Product Benchmarking
                        6.7.4. Strategic Initiatives
                   6.8. Sichuan Kelun Pharmaceutical Co. Ltd.
                        6.8.1. Company Overview
                        6.8.2. Financial Performance
                        6.8.3. Product Benchmarking
                        6.8.4. Strategic Initiatives
List of Tables

1. Parenteral nutrition - Industry Snapshot
2. Parenteral nutrition market, by type of nutrition, 2013 - 2024 (USD billion)
3. Parenteral nutrition market, by region, 2013 - 2024 (USD billion)
4. Parenteral nutrition market - Key market drivers analysis
5. Parenteral nutrition market - Key market restraints analysis
6. North America parenteral nutrition market, by type of nutrition, 2013 - 2024 (USD billion)
7. U.S. parenteral nutrition market, by type of nutrition, 2013 - 2024 (USD billion)
8. Canada parenteral nutrition market, by type of nutrition, 2013 - 2024 (USD billion)
9. Europe parenteral nutrition market, by type of nutrition, 2013 - 2024 (USD billion)
10. UK parenteral nutrition market, by type of nutrition, 2013 - 2024 (USD billion)
11. Germany parenteral nutrition market, by type of nutrition, 2013 - 2024 (USD billion)
12. Asia Pacific parenteral nutrition market, by type of nutrition, 2013 - 2024 (USD billion)
13. Japan parenteral nutrition market, by type of nutrition, 2013 - 2024 (USD billion)
14. China parenteral nutrition market, by type of nutrition, 2013 - 2024 (USD billion)
15. Latin America parenteral nutrition market, by type of nutrition, 2013 - 2024 (USD billion)
16. Brazil parenteral nutrition market, by type of nutrition, 2013 - 2024 (USD billion)
17. Mexico parenteral nutrition market, by type of nutrition, 2013 - 2024 (USD billion)
18. MEA parenteral nutrition market, by type of nutrition, 2013 - 2024 (USD billion)
19. South Africa parenteral nutrition market, by type of nutrition, 2013 - 2024 (USD billion)
20. Saudi Arabia parenteral nutrition market, by type of nutrition, 2013 - 2024 (USD billion) 


List of Figures

1. Parenteral nutrition market segmentation
2. Global parenteral nutrition market revenue, 2013 - 2024
3. Parenteral nutrition market dynamics
4. Key opportunities prioritized
5. Parenteral nutrition market Analysis - Porter's
6. Parenteral nutrition market Analysis - PESTEL Analysis
7. Global parenteral nutrition market , by type of nutrition, 2013 - 2024 (USD billion)
8. Carbohydrate market, 2013 - 2024 (USD billion)
9. Parenteral lipid emulsion market, 2013 - 2024 (USD billion)
10. Single dose amino acid solution market, 2013 - 2024 (USD billion)
11. Trace elements market, 2013 - 2024 (USD billion)
12. Vitamins and minerals market, 2013 - 2024 (USD billion)
13. Global parenteral nutrition market , by region 2013 to 2024 (USD billion)
14. North America parenteral nutrition market, by type of nutrition, 2013 to 2024 (USD billion)
15. U.S. parenteral nutrition market, by type of nutrition, 2013 to 2024 (USD billion)
16. Canada parenteral nutrition market, by type of nutrition, 2013 to 2024 (USD billion)
17. Europe parenteral nutrition market, by type of nutrition, 2013 to 2024 (USD billion)
18. UK parenteral nutrition market, by type of nutrition, 2013 to 2024 (USD billion)
19. Germany parenteral nutrition market, by type of nutrition, 2013 to 2024 (USD billion)
20. Asia Pacific parenteral nutrition market, by type of nutrition, 2013 to 2024 (USD billion)
21. Japan parenteral nutrition market, by type of nutrition, 2013 to 2024 (USD billion)
22. China parenteral nutrition market, by type of nutrition, 2013 to 2024 (USD billion)
23. Latin America parenteral nutrition market, by type of nutrition, 2013 to 2024 (USD billion)
24. Brazil parenteral nutrition market, by type of nutrition, 2013 to 2024 (USD billion)
25. Mexico parenteral nutrition market, by type of nutrition, 2013 to 2024 (USD billion)
26. MEA parenteral nutrition market, by type of nutrition, 2013 to 2024 (USD billion)
27. South Africa parenteral nutrition market, by type of nutrition, 2013 to 2024 (USD billion)
28. Saudi Arabia parenteral nutrition market, by type of nutrition, 2013 to 2024 (USD billion)

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global contact lenses market size is estimated to reach USD 12.5 billion by 2020, according to a new industry report by Radiant Insights, Inc. Growing number of ophthalmic disorder observed in global population especially children is likely to drive

Read More...

Global automotive ECU market is projected to be valued at USD 45.98 billion by 2020, as per a new research report by Radiant Insights, Inc. Rising use in infotainment systems coupled with high deployment in electric vehicles applications is expected

Read More...

Global automotive relay market is anticipated to reach USD 12 billion by 2020, as per a new research report by Radiant Insights, Inc. Rising need for high-frequency signals in automotive industry is expected to drive demand. These relays enhance driv

Read More...

Global commercial drone market size is estimated to reach USD 2,069.6 million by 2022, as per a new research report by Radiant Insights, Inc. Increasing application of these machines in various industry sectors such as military, agriculture and energ

Read More...

Global advanced energy storage systems market size is anticipated to be valued at USD 24.8 billion by 2022, as per a new research report by Radiant Insights, Inc. Increasing energy consumption coupled with strong energy demand for industrial, commerc

Read More...
Choose License Type
Single User - US $4950
Multi User - US $7950
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify